Conservative treatment options for constipation due to primary dysfunctions of the colon-from irritable bowel syndrome to slow transit constipation;Medikaments-konservative Therapieoptionen der Obstipation bei primren Funktionsstrungen des Kolons-vom Reizdarmsyndrom bis zur Slow Transit Constipation

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 28, Issue 4, 2012, Pages 243-249

  Keller, Jutta ^a   Layer, Peter ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Functional constipation; Irritable bowel syndrome; Slow transit constipation

Indexed keywords

ARTICLE; CONSERVATIVE TREATMENT; CONSTIPATION; INTESTINAL DYSMOTILITY; IRRITABLE COLON; PATHOGENESIS; PRACTICE GUIDELINE; RECTUM DISEASE;

EID: 84866161829     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000341992     Document Type: Article

References (28)

1. Mugie SM, Benninga MA, Di Lorenzo C: Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol 2011;25:3-18.
2. Andresen V, Enck P, Frieling T, et al.: S2k-Leitlinie chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie der DGNM und DGVS. Konsensuskonferenz vom 14.09. und 17.09.2011.
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
4. Layer P, Andresen V, Pehl C, et al.: S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft f Verdauungs-und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f Neurogastroenterologie und Motilit (DGNM). Z Gastroenterol 2011;49:237-293.
5. Keller J, Wedel T, Seidl H, Kreis ME, Andresen V, Prei JC, Layer P, van der Voort I: S3-Leitlinie der Deutschen Gesellschaft f Verdauungs-und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f Neurogastroenterologie und Motilit (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilitsst-ungen. Z Gastroenterol 2011;49:374-390.
6. Keller J, Layer P: Intestinal and anorectal motility and functional disorders. Best Pract Res Clin Gastroenterol 2009;23:407-423.
7. Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M: Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009;137:1425-1434.
8. Pehl C: Sekunde Form der Obstipation aufgrund von medikamenten Nebenwirkungen und endokrinen, neurologischen und psychiatrischen Erkrankungen-medikament-konservative Therapieoptionen. Viszeralmedizin 2012;28:250-254.
9. Seidl H, Gundling F, Pehl C, Pfeiffer A, Schepp W, Schmidt T: Small bowel motility in functional chronic constipation. Neurogastroenterol Motil 2009;21:1278-e122.
10. Lembo A, Camilleri M: Chronic constipation. N Engl J Med 2003;349:1360-1368.
11. Keller J: Diagnostische Evaluation der Dndarmmotilit. Der Gastroenterologe 2011;6:211-217.
12. Camilleri M, Bharucha AE, di Lorenzo C, Hasler WL, Prather CM, Rao SS, Wald A: American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008;20:1269-1282.
13. Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T: The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut 2010;59:882-887.
14. Suares NC, Ford AC: Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011; 33:895-901.
15. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N: Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005;2:CD003460.
16. Chung BD, Parekh U, Sellin JH: Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 1999;28: 29-32. (Pubitemid 29011589)
17. Meshkinpour H, Selod S, Movahedi H, Nami N, James N, Wilson A: Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998;43:2379-2383. (Pubitemid 28531307)
18. Speare GS: Melanosis coll; experimental observations on its production and elimination in twentythree cases. Am J Surg 1951;82:631-637.
19. Kinnunen O, Salokannel J: Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res 1987; 19:321-323. (Pubitemid 18051852)
20. Tatsuki M, Miyazawa R, Tomomasa T, Ishige T, Nakazawa T, Arakawa H: Serum magnesium concentration in children with functional constipation treated with magnesium oxide. World J Gastroenterol 2011;17:779-783.
21. Johanson JF, Kralstein J: Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007;25:599-608.
22. Camilleri M, Kerstens R, Rykx A, Vandeplassche L: A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008; 358:2344-2354. (Pubitemid 351749158)
23. Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L: Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357-365.
24. Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R: Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther 2009;29:329-341.
25. Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R: Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008;27:685-696. (Pubitemid 351406304)
26. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR: Effect of 5 days linaclotide on transit and bowel function in females with constipationpredominant irritable bowel syndrome. Gastroenterology 2007;133:761-768. (Pubitemid 47374145)
27. Johnston JM, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, O'Dea C, Baird M, Lembo AJ: Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 2010;139:1877-1886.e2.
28. Zehler O, Kutup A: Indikationen und Therapieoptionen aus chirurgischer Sicht bei der Kolontransitst-ung. Viszeralmedizin 2012;28:255-259.